Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial
- PMID: 36331570
- DOI: 10.1007/s00134-022-06912-w
Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial
Erratum in
-
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.Intensive Care Med. 2023 Mar;49(3):381-383. doi: 10.1007/s00134-023-06976-2. Intensive Care Med. 2023. PMID: 36757471 No abstract available.
Abstract
Purpose: To assess whether pre-existing chronic kidney disease (CKD) modified the relationship between the strategy for renal-replacement theraphy (RRT) initiation and clinical outcomes in the STARRT-AKI trial.
Methods: This was a secondary analysis of a multi-national randomized trial. We included patients who had documented pre-existing estimated glomerular filtration rate (eGFR) data prior to hospitalization, and we defined CKD as an eGFR ≤ 59 mL/min/1.73 m2. The primary outcome was all-cause mortality at 90 days. Secondary outcomes included RRT dependence and RRT-free days at 90 days. We used logistic and linear regression and interaction testing to explore the effect of RRT initiation strategy on outcomes by CKD status.
Results: We studied 1121 patients who had pre-hospital measures of kidney function. Of these, 432 patients (38.5%) had CKD. The median (IQR) baseline serum creatinine was 130 (114-160) and 76 (64-90) µmol/L for those with and without CKD, respectively. Patients with CKD were older and more likely to have cardiovascular comorbidities and diabetes mellitus. Patients with CKD had higher 90-day mortality (47% vs. 40%, p < 0.001) compared to those without CKD, though this was not significant after covariate adjustment (adjusted odds ratio [aOR], 1.05; 95% CI, 0.79-1.41). Patients with CKD were more likely to remain RRT dependent at 90 days (14% vs. 8%; aOR, 1.89; 95% CI, 1.05-3.43). CKD status did not modify the effect of RRT initiation strategy on 90-day mortality. Among patients with CKD, allocation to the accelerated strategy conferred more than threefold greater odds of RRT dependence at 90 days (aOR 3.18; 95% CI, 1.41-7.91) compared with the standard strategy, whereas RRT initiation strategy had no effect on this outcome among those without CKD (aOR 0.71; 95% CI, 0.34-1.47, p value for interaction, 0.009).
Conclusion: In this secondary analysis of the STARRT-AKI trial, an accelerated strategy of RRT initiation conferred a higher risk of 90-day RRT dependence among patients with pre-existing CKD; however, no effect was observed in the absence of CKD.
Keywords: Acute kidney injury; Dialysis; Mortality; Recovery; Renal-replacement therapy.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Association of Age, Frailty, and Strategy for Initiation of Renal-Replacement Therapy: A Post Hoc analysis of the STARRT-Acute Kidney Injury Trial.Blood Purif. 2024;53(10):781-792. doi: 10.1159/000540323. Epub 2024 Jul 24. Blood Purif. 2024. PMID: 39047692 Clinical Trial.
-
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.Crit Care. 2022 Nov 29;26(1):367. doi: 10.1186/s13054-022-04233-4. Crit Care. 2022. PMID: 36447221 Free PMC article. Clinical Trial.
-
Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials.J Crit Care. 2024 Aug;82:154767. doi: 10.1016/j.jcrc.2024.154767. Epub 2024 Mar 11. J Crit Care. 2024. PMID: 38461657 Clinical Trial.
-
Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review & meta-analysis of randomized controlled trials.BMC Nephrol. 2017 Feb 28;18(1):78. doi: 10.1186/s12882-017-0486-9. BMC Nephrol. 2017. PMID: 28245793 Free PMC article.
-
Timing of renal-replacement therapy in intensive care unit-related acute kidney injury.Curr Opin Crit Care. 2021 Dec 1;27(6):573-581. doi: 10.1097/MCC.0000000000000891. Curr Opin Crit Care. 2021. PMID: 34757994 Review.
Cited by
-
Does ability and willingness to use continuous RRT improve patient outcomes? A few answers, plenty of questions and opportunities for research.Intensive Care Med. 2025 Jul 21. doi: 10.1007/s00134-025-08045-2. Online ahead of print. Intensive Care Med. 2025. PMID: 40691372 No abstract available.
-
Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy.JAMA Netw Open. 2024 Feb 5;7(2):e240243. doi: 10.1001/jamanetworkopen.2024.0243. JAMA Netw Open. 2024. PMID: 38393726 Free PMC article.
-
The kidney: the critical organ system for guiding nutrition therapy in the ICU-patient?Crit Care. 2024 Aug 7;28(1):266. doi: 10.1186/s13054-024-05052-5. Crit Care. 2024. PMID: 39113139 Free PMC article.
-
[Recent developments in acute kidney injury : Definition, biomarkers, subphenotypes, and management].Med Klin Intensivmed Notfmed. 2024 Jun;119(5):339-345. doi: 10.1007/s00063-024-01142-y. Epub 2024 Apr 29. Med Klin Intensivmed Notfmed. 2024. PMID: 38683229 Free PMC article. Review. German.
-
Acute kidney injury: when and how to start renal replacement therapy.Intensive Care Med. 2025 Jun;51(6):1172-1175. doi: 10.1007/s00134-025-07933-x. Epub 2025 May 19. Intensive Care Med. 2025. PMID: 40387887 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous